Transcriptional profiling of Candida glabrata during phagocytosis by neutrophils and in the infected mouse spleen

Infection and Immunity

Volumn 81, Issue 4, 2013, Pages 1325-1333

  Fukuda, Yuichi ^a   Tsai, Huei Fung ^a   Myers, Timothy G ^a   Bennett, John E ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ASPARTIC PROTEINASE; CARBOHYDRATE; CHOLESTEROL; ERGOSTEROL; NITROGEN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOPHAGY; CANDIDA GLABRATA; CELL WALL; CONTROLLED STUDY; DOWN REGULATION; FATTY ACID METABOLISM; FUNGAL CELL; GENE EXPRESSION; GENETIC TRANSCRIPTION; MOUSE; NEUTROPHIL; NONHUMAN; PHAGOCYTE; PHAGOCYTOSIS; PRIORITY JOURNAL; RNA TRANSLATION; SPLEEN; UPREGULATION;

ANIMALS; CANDIDA GLABRATA; CANDIDIASIS; DISEASE MODELS, ANIMAL; FEMALE; GENE EXPRESSION PROFILING; HUMANS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICROARRAY ANALYSIS; NEUTROPHILS; PHAGOCYTOSIS; REAL-TIME POLYMERASE CHAIN REACTION; SPLEEN;

EID: 84875485722     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.00851-12     Document Type: Article

References (32)

1. Klevay MJ, Horn DL, Neofytos D, Pfaller MA, Diekema DJ. 2009. Initial treatment and outcome of Candida glabrata versus Candida albicans bloodstream infection. Diagn. Microbiol. Infect. Dis. 64:152-157.
2. MacCallum DM, Odds FC. 2005. Temporal events in the intravenous challenge model for experimental Candida albicans infections in female mice. Mycoses 48:151-161.
3. phox -/- knockout mice. Antimicrob. Agents Chemother. 46: 1240-1245.
4. Horn DL, Neofytos D, Anaissie EJ, Fishman JA, Steinbach WJ, Olysie AJ, Marr KA, Pfaller MA, Chang C-H, Webster KM. 2009. Epidemiology and outcomes of candidemia in 2019 patients: data from the prospective antifungal therapy alliance registry. Clin. Infect. Dis. 48:1695-1703.
5. Kan VL, Geber A, Bennett JE. 1996. Enhanced oxidative killing of azoleresistant Candida glabrata strains with ERG11 deletions. Antimicrob. Agents Chemother. 40:1717-1719.
6. Falcone EL, Holland SM. 2012. Invasive fungal infection in chronic granulomatous disease: insights into pathogenesis and management. Curr. Opin. Infect. Dis. 25:658-669.
7. Kaur R, Ma B, Cormack BP. 2007. A family of glycosylphosphatidylinositol-linked aspartyl proteases is required for virulence of Candida glabrata. Proc. Natl. Acad. Sci. U. S. A. 104:7628-7633.
8. Roetzer A, Gratz N, Kovarik P, Schüller C. 2010. Autophagy supports Candida glabrata survival during phagocytosis. Cell. Microbiol. 12:199-216.
9. Walker LA, MacCallum DM, Bertram G, Gow NAR, Odds FC, Brown AJP. 2009. Genome-wide analysis of Candida albicans gene expression patterns during infection of the mammalian kidney. Fungal Genet. Biol. 46:210-219.
10. Thewes S, Kretschmar M, Park H, Schaller M, Filler SG, Hube B. 2007. In vivo and ex vivo comparative transcriptional profiling of invasive and non-invasive Candida albicans isolate identifies genes associated with tissue invasion. Mol. Microbiol. 63:1606-1628.
11. Hu G, Cheng PY, Sham A, Perfect JR, Kronstad JW. 2008. Metabolic adaptation in Cryptococcus neoformans during early murine infection. Mol. Microbiol. 69:1456-1475.
12. McDonagh R, Fedorova ND, Crabtree J, Yu Y, Kim S, Chen D, Loss O, Cairns T, Goldman G, Armstrong-James D, Haynes K, Haas H, Schrettl M, May G, Nierman WC, Bignell E. 2008. Sub-telomere directed gene expression during initiation of invasive aspergillosis. PLoS Pathog. 4:e1000154.
13. Andes D, Lopak A, Pitula A, Marchillo K, Clark J. 2005. A simple approach for estimating gene expression in Candida albicans directly from a systemic infection site. J. Infect. Dis. 192:893-900.
14. Enjalbert B, MacCallum D, Odds FC, Brown AFP. 2007. Niche-specific activation of the oxidative stress response by the pathogenic fungus Candida albicans. Infect. Immun. 75:2143-2151.
15. Brown AJP, Odds FC, Gow NAR. 2007. Infection-related gene expression in Candida albicans. Curr. Opin. Microbiol. 10:307-313.
16. Wilson D, Thewes S, Zakikhany K, Fradin C, Albrecht A, Almeida R, Brunke S, Grosse K, Martin R, Mayer F, Leonhardt I, Schild L, Seider K, Skibbe M, Slesiona S, Waechtler B, Jacobsen I, Hube B. 2009. Identifying infection-associated genes of Candida albicans in the postgenomic era. FEMS Yeast Res. 9:688-700.
17. Sherman F. 1991. Getting started with yeast. Methods Enzymol. 194:3-21.
18. Lorenz MC, Bender JA, Fink GR. 2004. Transcriptional response of Candida albicans upon internalization by macrophages. Eukaryot. Cell 3:1076-1087.
19. Tsai H-F, Sammons LR, Zhang X, Suffis SD, Su Q, Myers TG, Marr KA, Bennett JE. 2010. Microarray and molecular analyses of the azole resistance mechanism in Candida glabrata oropharyngeal isolates. Antimicrob. Agents Chemother. 54:3308-3317.
20. Fradin C, De Groot P, MacCallum D, Schaller N, Klis F, Odds FC, Hube B. 2005. Granulocytes govern the transcriptional response, morphology and proliferation of Candida albicans in human blood. Mol. Microbiol. 56:397-415.
21. Rubin-Bejerano I, Fraser I, Grisafi P, Fink GR. 2003. Phagocytosis by neutrophils induces an amino acid deprivation response in Saccharomyces cerevisiae and Candida albicans. Proc. Natl. Acad. Sci. U. S. A. 100:11007-11012.
22. Roetzer A, Gregori C, Jennings AM, Quintin J, Ferrendon D, Butler G, Kuchler K, Ammerer G, Schüller C. 2008. Candida glabrata environmental stress response involves Saccharomyces cerevisiae Msn2/5 othologous transcription factors. Mol. Microbiol. 69:603-620.
23. Rouillon A, Barbey R, Patton EE, Tyers M, Thomas D. 2000. Feedback-regulated degradation of the transcriptional activator Met4 is triggered by the SCF(Met30) complex. EMBO J. 19:282-294.
24. Roetzer A, Klopf E, Gratz N, Marcet-Houben M, Hiller E, Rupp S, Gabaldón T, Kovarik P, Schüller C. 2011. Regulation of Candida glabrata oxidative stress is adapted to host environment. FEBS Lett. 585:319-327.
25. Brünke S, Hübe B. 2013. Two unlike cousins: Candida albicans and C. glabrata infection strategies. Cell. Microbiol.
26. Tsai H-F, Bard M, Izumikawa K, Krol AA, Sturm AM, Culbertson NT, Pierson CA, Bennett JE. 2004. Candida glabrata erg1 mutant with increased sensitivity to azoles and low oxygen tension. Antimicrob. Agents Chemother. 48:2483-2489.
27. Oku M, Sakai Y. 2010. Peroxisomes as dynamic organelles: autophagic degradation. FEBS J. 277:3289-3294.
28. Lorenz MC, Fink GR. 2001. The glyoxylate cycle is required for fungal virulence. Nature 412:83-86.
29. Till A, Lakhani R, Burnett S, Subramani S. 2012. Pexophagy: the selective degradation of peroxisomes. Int. J. Cell Biol. 2012:512721.
30. Miyazaki T, Inamine T, Yamauchi S, Nagayoshi Y, Saijo T, Izumikawa I, Seki M, Kakeya H, Yamamoto Y, Yanagihara K, Miyazaki Y, Kohno S. 2011. Role of the Slt2 mitogen-activated protein kinase pathway in cell wall integrity and virulence in Candida glabrata. FEMS Yeast Res. 11:449-456.
31. Manjithaya R, Jain S, Farre J-C, Subramani S. 2010. A yeast MAPK cascade regulated pexophagy but not other autophagy pathways. J. Cell Biol. 189:303-310.
32. Cuéllar-Cruz M, Biones-Martin-del-Campo M, Cañas-Villamar I, Montalvo-Arredondo J, Riego-Ruiz L, Castaño I, de las Peñas A. 2008. High resistance to oxidative stress in the fungal pathogen Candida glabrata is mediated by a single catalase, Cta1p, and is controlled by the transcription factors Yap1p, Skn7p, Msn2p, and Msn4p. Eukaryot. Cell 7:814-825.